These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2150683)

  • 1. [The neurobiology and molecular genetics of Alzheimer's disease: the diagnostic markers and therapy].
    Cacabelos R
    Med Clin (Barc); 1990 Oct; 95(13):502-16. PubMed ID: 2150683
    [No Abstract]   [Full Text] [Related]  

  • 2. The involvement of amyloid associated proteins in the formation of beta-protein filaments in Alzheimer's disease.
    Potter H; Ma J; Das S; Kayyali U
    Prog Clin Biol Res; 1994; 390():57-71. PubMed ID: 7724651
    [No Abstract]   [Full Text] [Related]  

  • 3. Heritability of plasma amyloid beta in typical late-onset Alzheimer's disease pedigrees.
    Ertekin-Taner N; Graff-Radford N; Younkin LH; Eckman C; Adamson J; Schaid DJ; Blangero J; Hutton M; Younkin SG
    Genet Epidemiol; 2001 Jul; 21(1):19-30. PubMed ID: 11443731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The proteins and genes of Alzheimer's disease.
    Glenner GG
    Biomed Pharmacother; 1988; 42(9):579-84. PubMed ID: 3071381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical genetics of dementing illness.
    Heston LL
    Neurol Clin; 1986 May; 4(2):439-46. PubMed ID: 3012307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of familial Alzheimer's disease to segregate with the A4-amyloid gene in several European families.
    Van Broeckhoven C; Genthe AM; Vandenberghe A; Horsthemke B; Backhovens H; Raeymaekers P; Van Hul W; Wehnert A; Gheuens J; Cras P
    Nature; 1987 Sep 10-16; 329(6135):153-5. PubMed ID: 3306405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease: from molecular biology to neuropsychiatry.
    Cummings JL
    Semin Clin Neuropsychiatry; 2003 Jan; 8(1):31-6. PubMed ID: 12567330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frame-shifted amyloid precursor protein found in Alzheimer's disease and Down's syndrome increases levels of secreted amyloid beta40.
    van Dijk R; Fischer DF; Sluijs JA; Sonnemans MA; Hobo B; Mercken L; Mann DM; Hol EM; van Leeuwen FW
    J Neurochem; 2004 Aug; 90(3):712-23. PubMed ID: 15255950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease or Alzheimer's diseases? Clues from molecular epidemiology.
    Hyman BT
    Ann Neurol; 1996 Aug; 40(2):135-6. PubMed ID: 8773592
    [No Abstract]   [Full Text] [Related]  

  • 10. Altered gene expression and neuropathology in Alzheimer's disease.
    Brasnjevic I; Steinbusch HW; Schmitz C
    Neurobiol Aging; 2006 Aug; 27(8):1081-3. PubMed ID: 16111786
    [No Abstract]   [Full Text] [Related]  

  • 11. The genetic defect in familial Alzheimer's disease is not tightly linked to the amyloid beta-protein gene.
    Tanzi RE; St George-Hyslop PH; Haines JL; Polinsky RJ; Nee L; Foncin JF; Neve RL; McClatchey AI; Conneally PM; Gusella JF
    Nature; 1987 Sep 10-16; 329(6135):156-7. PubMed ID: 2888020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic mouse models of Alzheimer's disease: phenotype and application.
    Higgins GA; Jacobsen H
    Behav Pharmacol; 2003 Sep; 14(5-6):419-38. PubMed ID: 14501255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A modified beta-amyloid hypothesis: intraneuronal accumulation of the beta-amyloid peptide--the first step of a fatal cascade.
    Wirths O; Multhaup G; Bayer TA
    J Neurochem; 2004 Nov; 91(3):513-20. PubMed ID: 15485483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging?
    Swerdlow RH
    Neurobiol Aging; 2007 Oct; 28(10):1465-80. PubMed ID: 16876913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An array of genes implicated in Alzheimer's disease.
    LaFerla FM
    Neurobiol Aging; 2006 Aug; 27(8):1078-80. PubMed ID: 16112251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NACP/alpha-synuclein, NAC, and beta-amyloid pathology of familial Alzheimer's disease with the E184D presenilin-1 mutation: a clinicopathological study of two autopsy cases.
    Yokota O; Terada S; Ishizu H; Ujike H; Ishihara T; Nakashima H; Yasuda M; Kitamura Y; Uéda K; Checler F; Kuroda S
    Acta Neuropathol; 2002 Dec; 104(6):637-48. PubMed ID: 12410385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid beta concentrations in older people with Down syndrome and dementia.
    Jones EL; Hanney M; Francis PT; Ballard CG
    Neurosci Lett; 2009 Feb; 451(2):162-4. PubMed ID: 19111900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurodegenerative disease: amyloid pores from pathogenic mutations.
    Lashuel HA; Hartley D; Petre BM; Walz T; Lansbury PT
    Nature; 2002 Jul; 418(6895):291. PubMed ID: 12124613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of peripheral markers of copper homeostasis in Alzheimer's disease patients: implications in aetiology and therapy.
    Rossi L; Squitti R; Calabrese L; Rotilio G; Rossini PM
    J Nutr Health Aging; 2007; 11(5):408-17. PubMed ID: 17657362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.
    Lemere CA; Blusztajn JK; Yamaguchi H; Wisniewski T; Saido TC; Selkoe DJ
    Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.